Unveiling the potential of prodrug and drug-conjugate strategies in treatment of diabetes mellitus and its complications Neha V. BhilareRushikesh ShedgeAjinkya More Review Article 29 January 2024 Pages: 337 - 353
Exploring the latest breakthroughs in rhodesain inhibitors for African trypanosomiasis Diego Eidy ChibaGuilherme Felipe dos Santos FernandesCauê Benito Scarim Review Article 02 February 2024 Pages: 354 - 369
Insights on synthetic strategies and structure-activity relationship of donepezil and its derivatives Saraswati PatelSonika JainJaya Dwivedi Review Article 17 February 2024 Pages: 370 - 405
Targeting disease with benzoxazoles: a comprehensive review of recent developments Abdulrahman AbdullahiKeng Yoon Yeong Review Article Open access 18 February 2024 Pages: 406 - 438
Synthesis and pharmacological activities of Schiff bases with some transition metal complexes: a review Kibrom MezgebeEndale Mulugeta Review Article 19 February 2024 Pages: 439 - 463
Benzocaine-N-acylindoline conjugates: synthesis and antiviral activity against Coxsackievirus B3 Alexandrina S. VolobuevaAnton A. ShetnevSergey V. Baykov Original Research Article 13 February 2024 Pages: 464 - 475
Novel biologically active pyridine derivatives: Synthesis, structure characterization, in vitro antimicrobial evaluation and structure-activity relationship Mohamed A. ElsayedAlshaimaa M. ElsayedFarid M. Sroor Original Research Article Open access 14 February 2024 Pages: 476 - 491
Selectivity of N(2)-substituted oxotriazinoindole aldose reductase inhibitors is determined by the interaction pattern with Pro301-Arg312 loop of aldehyde reductase Lucia KováčikováSunil GaikwadMilan Štefek Original Research Article Open access 14 February 2024 Pages: 492 - 503
Identification of novel benzoyl hydrazine derivatives as activators of neddylation pathway to inhibit the tumor progression in vitro Xuan WangSumeng GuanMoran Sun Original Research Article 15 February 2024 Pages: 504 - 517
Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics Miriam GirardiniDiana MachadoMarco Pieroni Original Research Article 17 February 2024 Pages: 518 - 531
Synthesis, characterization, and anticancer activity of syringaldehyde-derived chalcones against female cancers Qionghui PanHuamao YangFaqing Ye Original Research Article 19 February 2024 Pages: 532 - 547
Development of novel chalcone derivatives as multifunctional agents for the treatment of Alzheimer’s disease Xinjuan LiYuting LiZhipei Sang Original Research Article 26 February 2024 Pages: 548 - 561